Expanded Disability Status Scale
Expanded Disability Status Scale[edit | edit source]
The Expanded Disability Status Scale (EDSS) is a method of quantifying disability in multiple sclerosis (MS) and monitoring changes in the level of disability over time. The scale was developed by John F. Kurtzke in 1983 and is widely used in clinical trials and in the assessment of patients with MS.
Description[edit | edit source]
The EDSS quantifies disability in eight Functional Systems (FS) and allows neurologists to assign a Functional System Score (FSS) in each of these. The FS include:
- Pyramidal (motor function)
- Cerebellar (coordination)
- Brainstem (speech and swallowing)
- Sensory (touch and pain)
- Bowel and bladder function
- Visual function
- Cerebral (mental) function
- Other
The EDSS score ranges from 0 to 10 in 0.5 increments, with 0 being normal neurological examination and 10 being death due to MS. Scores from 1.0 to 4.5 refer to people with MS who are fully ambulatory, while scores from 5.0 to 9.5 are defined by the impairment to ambulation.
Scoring[edit | edit source]
The scoring is based on a neurological examination and the patient's ability to walk. The scale is heavily weighted towards ambulation, with higher scores indicating greater disability:
- 0.0: Normal neurological exam
- 1.0-1.5: No disability, minimal signs in one FS
- 2.0-2.5: Minimal disability in one FS
- 3.0-3.5: Moderate disability in one FS
- 4.0-4.5: Significant disability but able to walk without aid
- 5.0-5.5: Disability severe enough to impair full daily activities
- 6.0-6.5: Requires a walking aid
- 7.0-7.5: Restricted to wheelchair
- 8.0-8.5: Restricted to bed or chair
- 9.0-9.5: Confined to bed, unable to communicate effectively
- 10.0: Death due to MS
Limitations[edit | edit source]
The EDSS is criticized for its emphasis on ambulation and its insensitivity to changes in other areas of disability, such as cognitive function. It may not fully capture the impact of MS on a patient's quality of life. Despite these limitations, it remains a standard tool in both clinical practice and research.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
